Novo Nordisk
NVO
#76
Rank
C$304.72 B
Marketcap
C$59.37
Share price
-8.16%
Change (1 day)
-50.84%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): C$29.32 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are C$47.21 Billion. In 2024 the company made an earning of C$25.92 Billion, an increase over its 2023 earnings that were of C$21.10 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$29.32 B13.1%
2024 C$25.92 B22.84%
2023 C$21.10 B57.81%
2022 C$13.37 B5.24%
2021 C$12.70 B12.38%
2020 C$11.30 B13.11%
2019 C$9.99 B-3.45%
2018 C$10.35 B1.88%
2017 C$10.16 B4.3%
2016 C$9.74 B10.32%
2015 C$8.83 B7.47%
2014 C$8.21 B3.4%
2013 C$7.94 B19.09%
2012 C$6.67 B15.58%
2011 C$5.77 B16.58%
2010 C$4.95 B25.66%
2009 C$3.94 B10.68%
2008 C$3.56 B55.82%
2007 C$2.28 B7.02%
2006 C$2.13 B19.05%
2005 C$1.79 B10.55%
2004 C$1.62 B
2002 C$1.14 B-14.39%
2001 C$1.33 B-52.82%
2000 C$2.82 B250%
1999 C$0.80 B31.21%
1998 C$0.61 B34.31%
1997 C$0.45 B11.46%
1996 C$0.41 B9.03%
1995 C$0.37 B-3.15%
1994 C$0.38 B-0.67%
1993 C$0.39 B45.38%
1992 C$0.26 B-13.81%
1991 C$0.31 B37.12%
1990 C$0.22 B-0.79%
1989 C$0.23 B26.2%
1988 C$0.18 B24.97%
1987 C$0.14 B-0.9%
1986 C$0.14 B-7.78%
1985 C$0.15 B24.87%
1984 C$0.12 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$16.23 B-43.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$30.82 B 7.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$12.46 B-56.34%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
C$11.00 B-61.46%๐Ÿ‡บ๐Ÿ‡ธ USA